Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
BioSpace
April 14, 2021
BioSpace
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, and Lonza today announced that the companies have entered into an agreement for the manufacture of ATYR2810, aTyr's monoclonal antibody targeting Neuropilin-2 (NRP2) that is currently in preclinical development for cancer.
Reuters Editorial
June 5, 2020
IN
Swiss contract drug manufacturer Lonza Group on Friday named Roche manager Pierre-Alain Ruffieux as its new chief executive, effective Nov. 1, underscoring its focus on its fast-growing pharmaceuticals business.
References
Organization
CompanyCompany attributes
Biotechnology
Stem cell
Healthcare
Agriculture
Materials science
Pharmaceutical industry
Manufacturing
Disinfectant
Basel
Switzerland
China
Guangzhou
Nanjing
Tokyo
Hyderabad
VerviersCompany Operating Status
Active
B2X
B2BSubsidiary
HansaBioMedLegal classification
AktiengesellschaftInvestors
VIBDUNS Number
480667059
Founded Date
January 1, 1897
Email Address
info@lonza.com
Phone Number
+41613168111
Total Funding Amount (USD)
2,014,050
Latest Funding Round Date
June 20, 2007
Competitors
CatalentExchange
OTC Markets GroupFormer CEO
Albert M. Baehny
Marc FunkAlso Known As
Lonza Biologics PLC
Patents Assigned (Count)
80
BelgiumCategories
Related Topics
Contributors
- 1
Aime Anne Nisay
QA Engineer of web and mobile applications - 2
Keeri Tramm
Accomplished manager, brand communicator, and burgeoning data analyst. - 3
Dawson Sewell
Writing about startups. - 4
Amy Sar
Data acquisition Golden, computational linguist - 5
Erin Scherfner
loading information... - 6
Katrina-Kay Pettitt
Data Duchess @ Golden - 7
Amy Tomlinson Gayle
QA Editor based in Austin, TX - 8
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 9
Megan Gustafson
Creative. Researcher. - 10
Aleksander Holm
Interested in understanding the world we live in.